Average Co-Inventor Count = 5.24
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xencor, Inc. (51 from 216 patents)
2. Amgen Inc. (1,970 patents)
51 patents:
1. 12398207 - Heterodimeric antibodies that bind CD3 and CLDN6
2. 12359002 - Heterodimeric antibodies that bind CD3 and tumor antigens
3. 12180302 - Heterodimeric antibodies that bind fibroblast activation protein
4. 12129309 - Heterodimeric antibodies that bind CD3 and CD38
5. 11945880 - Heterodimeric antibodies that bind CD3 and tumor antigens
6. 11859011 - Heterodimeric antibodies that bind CD3 and tumor antigens
7. 11840579 - Bispecific antibodies that bind to CD38 and CD3
8. 11739144 - Heterodimeric antibodies that bind CD3 and CLDN6
9. 11673972 - Heterodimeric antibodies that bind CD3 and tumor antigens
10. 11623957 - Heterodimeric antibodies that bind CD3 and PSMA
11. 11618788 - Optimized antibodies that target CD19
12. 11566080 - Compositions and methods for treating IgE-mediated disorders
13. 11472890 - Heterodimeric antibodies that bind ENPP3 and CD3
14. 11447552 - Methods and compositions for inhibiting CD32B expressing cells
15. 11434295 - Methods and compositions for inhibiting CD32B expressing cells